Login  
Volume 59
May 1998
Number 05

Brainstorms   [top]

215  Recognition Molecules Are Trailblazers for Axon Pathways

[Full Text]

Original Articles   [top]

217  Treatment of Major Depression in HIV-Seropositive Men

[Full Text]

225  Tobacco Smoking and Bipolar Disorder

[Full Text]

229  Dose-Response Efficacy of Paroxetine in Preventing Depressive Recurrences: A Randomized, Double-Blind Study

[Full Text]

233  Safety of Mirtazapine in Overdose

[Full Text]

236  Once- Versus Twice-Daily Venlafaxine Therapy in Major Depression: A Randomized, Double-Blind Study

[Full Text]

241  A Post Hoc Comparison of Paroxetine and Nortriptyline for Symptoms of Traumatic Grief

[Full Text]

246  A Double-Blind, Placebo-Controlled Trial of Nefazodone in the Treatment of Patients Hospitalized for Major Depression

[Full Text]

Letters to the Editor   [top]

254  Is Risk of Neuroleptic Malignant Syndrome Increased in the Postpartum Period?

[Full Text]

255  FINISH: Remembering the Discontinuation Syndrome

[Full Text]

255  Risperidone May Worsen Fluoxetine-Treated OCD

[Full Text]

256  Reply to Letter to the Editor "Risperidone May Worsen Fluoxetine-Treated OCD"

[Full Text]

256  Nefazodone and the Treatment of Panic

[Full Text]

257  Gastroesophageal Reflux as a Possible Result of Clozapine Treatment

[Full Text]

Book Reviews   [top]

258  Essential Psychopharmacology: Neuroscientific Basis and Practical Application

[Full Text]

258  The Biochemical Basis of Neuropharmacology, 7th ed

[Full Text]

Academic Highlights   [top]

259  Academic Highlights: Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part I: Unique Patient Populations

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx